WO2002007675A3 - Omega-conopeptides - Google Patents
Omega-conopeptides Download PDFInfo
- Publication number
- WO2002007675A3 WO2002007675A3 PCT/US2001/023041 US0123041W WO0207675A3 WO 2002007675 A3 WO2002007675 A3 WO 2002007675A3 US 0123041 W US0123041 W US 0123041W WO 0207675 A3 WO0207675 A3 WO 0207675A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- conopeptides
- agents
- propeptides
- omega
- encoding
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002513413A JP2004512025A (en) | 2000-07-21 | 2001-07-23 | Omega-conopeptide |
CA002416287A CA2416287A1 (en) | 2000-07-21 | 2001-07-23 | Omega-conopeptides |
EP01957214A EP1311283A4 (en) | 2000-07-21 | 2001-07-23 | Omega-conopeptides |
AU2001278982A AU2001278982A1 (en) | 2000-07-21 | 2001-07-23 | Omega-conopeptides |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21961600P | 2000-07-21 | 2000-07-21 | |
US60/219,616 | 2000-07-21 | ||
US26588801P | 2001-02-05 | 2001-02-05 | |
US60/265,888 | 2001-02-05 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002007675A2 WO2002007675A2 (en) | 2002-01-31 |
WO2002007675A3 true WO2002007675A3 (en) | 2003-03-06 |
Family
ID=26914073
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2001/023041 WO2002007675A2 (en) | 2000-07-21 | 2001-07-23 | Omega-conopeptides |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1311283A4 (en) |
JP (1) | JP2004512025A (en) |
AU (1) | AU2001278982A1 (en) |
CA (1) | CA2416287A1 (en) |
WO (1) | WO2002007675A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8673856B2 (en) | 2006-11-04 | 2014-03-18 | Anygen Co., Ltd. | Omega conotoxins |
WO2011032233A1 (en) * | 2009-09-21 | 2011-03-24 | The University Of Queensland | Novel omega conotoxin peptides |
JP6977979B2 (en) * | 2015-06-09 | 2021-12-08 | 国立大学法人大阪大学 | Nerve injury treatment or preventive medicine |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587454A (en) * | 1991-12-30 | 1996-12-24 | Neurex Corporation | Omega conopeptide compositions |
US5591821A (en) * | 1993-07-16 | 1997-01-07 | The University Of Utah | Omega-conotoxin peptides |
WO1999054350A1 (en) * | 1998-04-16 | 1999-10-28 | The University Of Queensland | Novel omega conotoxin peptides |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5231011A (en) * | 1991-04-18 | 1993-07-27 | University Of Utah | Segregated folding determinants for small disulfide-rich peptides |
-
2001
- 2001-07-23 CA CA002416287A patent/CA2416287A1/en not_active Abandoned
- 2001-07-23 AU AU2001278982A patent/AU2001278982A1/en not_active Abandoned
- 2001-07-23 EP EP01957214A patent/EP1311283A4/en not_active Withdrawn
- 2001-07-23 JP JP2002513413A patent/JP2004512025A/en active Pending
- 2001-07-23 WO PCT/US2001/023041 patent/WO2002007675A2/en not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5587454A (en) * | 1991-12-30 | 1996-12-24 | Neurex Corporation | Omega conopeptide compositions |
US5591821A (en) * | 1993-07-16 | 1997-01-07 | The University Of Utah | Omega-conotoxin peptides |
WO1999054350A1 (en) * | 1998-04-16 | 1999-10-28 | The University Of Queensland | Novel omega conotoxin peptides |
Non-Patent Citations (1)
Title |
---|
See also references of EP1311283A4 * |
Also Published As
Publication number | Publication date |
---|---|
CA2416287A1 (en) | 2002-01-31 |
WO2002007675A2 (en) | 2002-01-31 |
EP1311283A4 (en) | 2004-09-01 |
JP2004512025A (en) | 2004-04-22 |
EP1311283A2 (en) | 2003-05-21 |
AU2001278982A1 (en) | 2002-02-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2002072005A3 (en) | Linear y-carboxyglutamate rich conotoxins | |
IL157478A0 (en) | Method for the synthesis of 2', 3'-didehydronucleosides | |
WO2001066564A3 (en) | Gamma-secretase inhibitors | |
MXPA03001001A (en) | Anticonvulsant derivatives useful for the treatment of depression. | |
AU2002224927A1 (en) | Use of substituted imidazoazines, novel imidazoazines, methods for the production thereof, and agents containing these compounds | |
IL166710A0 (en) | Process for the preparation of 4-ÄÄ4-ÄÄ-(2-cyanoethenyl)2,6-dimethylphenylÜaminoÜ-2-pyrimidinylÜaminoÜbenzonitrile | |
WO2001060347A3 (en) | Method for treating ocular pain | |
MXPA03009527A (en) | Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds. | |
MXPA03010020A (en) | Process for the preparation of urea. | |
HUP0303034A3 (en) | Novel 7-azaindole-derivatives, use thereof as phosphodiesterase 4 inhibitors and method for producing the same | |
AU3657100A (en) | Use of water-soluble beta-(1,3) glucans as agents for producing therapeutic skintreatment agents | |
WO2002030870A3 (en) | Substituted c-cyclohexylmethylamine derivatives | |
WO2002007678A3 (en) | Mu-conopeptides | |
WO2003037863A3 (en) | Substituted indoles, method for production and use thereof for the inhibition of pain | |
IL157709A0 (en) | Process for the preparation of 1,2-benzisoxazole-3-acetic acid | |
WO2002007675A3 (en) | Omega-conopeptides | |
HUP0401577A3 (en) | Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses | |
MXPA03002926A (en) | Process for the synthesis of 2,2,6,6-tetramethyl-4-oxopiperidine. | |
IL144066A0 (en) | Process for the preparation of 1,1-cyclohexane diacetic monoamide | |
ZA200210361B (en) | Method of administering bishosphonates. | |
SI1468686T1 (en) | S-methyl-dihydro-ziprasidone for treatment of psychiatric disorders | |
HK1049485A1 (en) | DithiepinoÄ6,5-BÜpyridines, and related compositions, methods of producing and uses. | |
ZA200110172B (en) | Method of producing novolak resin. | |
AU5482001A (en) | Method for producing caprolactam on the basis of 6-aminocapronitrile and subsequent purification by crystallization | |
IL137364A (en) | Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2416287 Country of ref document: CA |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001957214 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2001278982 Country of ref document: AU |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWP | Wipo information: published in national office |
Ref document number: 2001957214 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2003131327 Country of ref document: RU Kind code of ref document: A Format of ref document f/p: F |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001957214 Country of ref document: EP |